The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
Open accessAbstract
The Hedgehog (Hh) pathway is activated in some human cancers, including medulloblastoma. The glioma-associated oncogene homolog (GLI) transcription factors are critical mediators of the activated Hh pathway, and their expression may be elevated in some tumors independent of upstream Hh signaling. Thus, therapies targeting GLI transcription factors may benefit a wide spectrum of patients with mutations at different nodal points of the Hh pathway. In this study, we present evidence that arsenic trioxide (ATO) suppresses human cancer cell growth and tumor development in mice by inhibiting GLI1. Mechanistically, ATO directly bound to GLI1 protein, inhibited its transcriptional activity, and decreased expression of endogenous GLI target genes. Consistent with this, ATO inhibited the growth of human cancer cell lines that depended on upregulated GLI expression in vitro and in vivo in a xenograft model of Ewing sarcoma. Furthermore, ATO improved survival of a clinically relevant spontaneous mouse model of medulloblastoma with activated Hh pathway signaling. Our results establish ATO as a Hh pathway inhibitor acting at the level of GLI1 both in vitro and in vivo. These results warrant the clinical investigation of ATO for tumors with activated Hh/GLI signaling, in particular patients who develop resistance to current therapies targeting the Hh pathway upstream of GLI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome
Hahn, H., Wicking, C., Zaphiropoulos, P. G., Gailani, M. R., Shanley, S., Chidambaram, A., Vorechovsky, I., Holmberg, E., Unden, A. B., Gillies, S., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81268-4 · Cited by 2,022
Specific Covalent Labeling of Recombinant Protein Molecules Inside Live Cells
Griffin, B. A., Adams, S. R., & Tsien, R. Y. (1998) · Science · doi:10.1126/science.281.5374.269 · Cited by 1,549
Vertebrate Smoothened functions at the primary cilium
Corbit, K. C., Aanstad, P., Singla, V., Norman, A. R., Stainier, D. Y. R., & Reiter, J. F. (2005) · Nature · doi:10.1038/nature04117 · Cited by 1,481
Patched1 Regulates Hedgehog Signaling at the Primary Cilium
Rohatgi, R., Milenkovic, L., & Scott, M. P. (2007) · Science · doi:10.1126/science.1139740 · Cited by 1,426
Hedgehog signalling in the mouse requires intraflagellar transport proteins
Huangfu, D., Liu, A., Rakeman, A. S., Murcia, N. S., Niswander, L., & Anderson, K. V. (2003) · Nature · doi:10.1038/nature02061 · Cited by 1,425
Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
Von Hoff, D. D., LoRusso, P. M., Rudin, C. M., Reddy, J. C., Yauch, R. L., Tibes, R., Weiss, G. J., Borad, M. J., Hann, C. L., Brahmer, J. R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905360 · Cited by 1,109
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
Rudin, C. M., Hann, C. L., Laterra, J., Yauch, R. L., Callahan, C. A., Fu, L., Holcomb, T., Stinson, J., Gould, S. E., Coleman, B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902903 · Cited by 1,019
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Yauch, R. L., Dijkgraaf, G. J. P., Alicke, B., Januario, T., Ahn, C. P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C. A., Tang, T., et al. (2009) · Science · doi:10.1126/science.1179386 · Cited by 839
Mutations in SUFU predispose to medulloblastoma
Taylor, M. D., Liu, L., Raffel, C., Hui, C.-C., Mainprize, T. G., Zhang, X., Agatep, R., Chiappa, S., Gao, L., Lowrance, A., et al. (2002) · Nature Genetics · doi:10.1038/ng916 · Cited by 806
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
Berman, D. M., Karhadkar, S. S., Hallahan, A. R., Pritchard, J. I., Eberhart, C. G., Watkins, D. N., Chen, J. K., Cooper, M. K., Taipale, J., Olson, J. M., et al. (2002) · Science · doi:10.1126/science.1073733 · Cited by 803
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Zhang, X.-W., Yan, X.-J., Zhou, Z.-R., Yang, F.-F., Wu, Z.-Y., Sun, H.-B., Liang, W.-X., Song, A.-X., Lallemand-Breitenbach, V., Jeanne, M., et al. (2010) · Science · doi:10.1126/science.1183424 · Cited by 785
Identification of an Amplified, Highly Expressed Gene in a Human Glioma
Kinzler, K. W., Bigner, S. H., Bigner, D. D., Trent, J. M., Law, M. L., O'Brien, S. J., Wong, A. J., & Vogelstein, B. (1987) · Science · doi:10.1126/science.3563490 · Cited by 681
Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells
Han, Y.-G., Spassky, N., Romaguera-Ros, M., Garcia-Verdugo, J.-M., Aguilar, A., Schneider-Maunoury, S., & Alvarez-Buylla, A. (2008) · Nature Neuroscience · doi:10.1038/nn2059 · Cited by 547
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
Lu, J., Chew, E.-H., & Holmgren, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701549104 · Cited by 526
Expansion of Bcr-Abl-Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation
Dierks, C., Beigi, R., Guo, G.-R., Zirlik, K., Stegert, M. R., Manley, P., Trussell, C., Schmitt-Graeff, A., Landwerlin, K., Veelken, H., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.08.003 · Cited by 517
Liu, A., Wang, B., & Niswander, L. A. (2005) · Development · doi:10.1242/dev.01894 · Cited by 494
Primary cilia can both mediate and suppress Hedgehog pathway–dependent tumorigenesis
Wong, S. Y., Seol, A. D., So, P.-L., Ermilov, A. N., Bichakjian, C. K., Epstein, E. H., Dlugosz, A. A., & Reiter, J. F. (2009) · Nature Medicine · doi:10.1038/nm.2011 · Cited by 469
Hallahan, A. R., Pritchard, J. I., Hansen, S., Benson, M., Stoeck, J., Hatton, B. A., Russell, T. L., Ellenbogen, R. G., Bernstein, I. D., Beachy, P. A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1813 · Cited by 444
May, S. R., Ashique, A. M., Karlen, M., Wang, B., Shen, Y., Zarbalis, K., Reiter, J., Ericson, J., & Peterson, A. S. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.08.050 · Cited by 428
REIFENBERGER, J., Wolter, M., Weber, R. G., Megahed, M., Ruzicka, T., Lichter, P., & Reifenberger, G. (1998) · PubMed · Cited by 426
The tumor promoter arsenite stimulates AP-1 activity by inhibiting a JNK phosphatase.
Cavigelli, M., Li, W. W., Lin, A., Su, B., Yoshioka, K., & Karin, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01017.x · Cited by 415
Pietsch, T., Waha, A., Koch, A., Kraus, J., Albrecht, S., Tonn, J. C., Sörensen, N., Berthold, F., Henk, B., Schmandt, N., et al. (1997) · PubMed · Cited by 373
Kapahi, P., Takahashi, T., Natoli, G., Adams, S. R., Chen, Y., Tsien, R. Y., & Karin, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007204200 · Cited by 359
Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
Nasr, R., Guillemin, M.-C., Ferhi, O., Soilihi, H., Peres, L., Berthier, C., Rousselot, P., Robledo-Sarmiento, M., Lallemand-Breitenbach, V., Gourmel, B., et al. (2008) · Nature Medicine · doi:10.1038/nm.1891 · Cited by 354
Primary cilia are required for cerebellar development and Shh-dependent expansion of progenitor pool
Spassky, N., Han, Y.-G., Aguilar, A., Strehl, L., Besse, L., Laclef, C., Romaguera Ros, M., Garcia-Verdugo, J. M., & Alvarez-Buylla, A. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.02.026 · Cited by 314
Lallemand-Breitenbach, V., Guillemin, M.-C., Janin, A., Daniel, M.-T., Degos, L., Kogan, S. C., Michael Bishop, J., & de Thé, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1043 · Cited by 305
Kim, J., Lee, J. J., Kim, J., Gardner, D., & Beachy, P. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006822107 · Cited by 304
Amplification of the gli gene in childhood sarcomas.
Roberts, W. M., Douglass, E., Peiper, S., Houghton, P. J., & Look, A. T. (1989) · PubMed · Cited by 246
Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma
Regl, G., Neill, G. W., Eichberger, T., Kasper, M., Ikram, M. S., Koller, J., Hintner, H., Quinn, A. G., Frischauf, A.-M., & Aberger, F. (2002) · Oncogene · doi:10.1038/sj.onc.1205748 · Cited by 209
Regulation of Gli1 Transcriptional Activity in the Nucleus by Dyrk1
Mao, J., Maye, P., Kogerman, P., Tejedor, F. J., Toftgard, R., Xie, W., Wu, G., & Wu, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206743200 · Cited by 190
The Smo/Smo Model: Hedgehog-Induced Medulloblastoma with 90% Incidence and Leptomeningeal Spread
Hatton, B. A., Villavicencio, E. H., Tsuchiya, K. D., Pritchard, J. I., Ditzler, S., Pullar, B., Hansen, S., Knoblaugh, S. E., Lee, D., Eberhart, C. G., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5092 · Cited by 188
Ågren, M., Kogerman, P., Kleman, M. I., Wessling, M., & Toftgård, R. (2004) · Gene · doi:10.1016/j.gene.2004.01.010 · Cited by 187
Dahlén, A., Fletcher, C. D. M., Mertens, F., Fletcher, J. A., Perez-Atayde, A. R., Hicks, M. J., Debiec-Rychter, M., Sciot, R., Wejde, J., Wedin, R., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63723-6 · Cited by 180
REN KCTD11 is a suppressor of Hedgehog signaling and is deleted in human medulloblastoma
Di Marcotullio, L., Ferretti, E., De Smaele, E., Argenti, B., Mincione, C., Zazzeroni, F., Gallo, R., Masuelli, L., Napolitano, M., Maroder, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400690101 · Cited by 179
GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
Beauchamp, E., Bulut, G., Abaan, O., Chen, K., Merchant, A., Matsui, W., Endo, Y., Rubin, J. S., Toretsky, J., & Üren, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806233200 · Cited by 170
Self-citationArsenic in Drinking-Water and Risk for Cancer in Denmark
Baastrup, R., Sørensen, M., Balstrøm, T., Frederiksen, K., Larsen, C. L., Tjønneland, A., Overvad, K., & Raaschou-Nielsen, O. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10623 · Cited by 170
Gli1 is important for medulloblastoma formation in Ptc1+/− mice
Kimura, H., Stephen, D. N., Joyner, A. L., & Curran, T. (2005) · Oncogene · doi:10.1038/sj.onc.1208567 · Cited by 148
Hayashi, T., Hideshima, T., Akiyama, M., Richardson, P. G. G., Schlossman, R. L., Chauhan, D., Munshi, N. C., Waxman, S., & Anderson, K. C. (2002) · PubMed · Cited by 148
Gli2 Is Targeted for Ubiquitination and Degradation by β-TrCP Ubiquitin Ligase
Saleem, M., Thiyagarajan, S., Elcheva, I. A., Saleem, M., Dlugosz, A. A., Mukhtar, H., & Spiegelman, V. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513203200 · Cited by 144
The EWS/FLI1 oncogenic transcription factor deregulates GLI1
Zwerner, J. P., Joo, J., Warner, K., Christensen, L., Hu‐Lieskovan, S., Triche, T. J., & May, W. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210991 · Cited by 135
Neßling, M., Richter, K., Schwäenen, C., Roerig, P., Wrobel, G., Weßendorf, S., Fritz, B., Bentz, M., Sinn, H., Radlwimmer, B., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.439.65.2 · Cited by 134
Gli1 regulates the proliferation and differentiation of HSCs and myeloid progenitors
Merchant, A. A., Joseph, G. A., Wang, Q., Brennan, S. K., & Matsui, W. H. (2010) · Blood · doi:10.1182/blood-2009-09-241703 · Cited by 133
Zhang, Q., Mao, J.-H., Liu, P., Huang, Q., Lu, J., Xie, Y., Weng, L., Zhang, Y., Chen, Q., Chen, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813142106 · Cited by 122
Fox, E., Razzouk, B. I., Widemann, B. C., Xiao, S., O'Brien, M., Goodspeed, W. J., Reaman, G. H., Blaney, S. M., Murgo, A. J., Balis, F. M., et al. (2007) · Blood · doi:10.1182/blood-2007-08-107839 · Cited by 119
GLI1 Is a Central Mediator of EWS/FLI1 Signaling in Ewing Tumors
Joo, J., Christensen, L., Warner, K., States, L. J., Kang, H.-G., Vo, K. T., Lawlor, E. R., & May, W. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007608 · Cited by 78
BCR-ABL mediates arsenic trioxide-induced apoptosis independently of its aberrant kinase activity.
Puccetti, E., Gueller, S., Orleth, A., Brüggenolte, N., Hoelzer, D. F., Ottmann, O. G., & Ruthardt, M. (2000) · PubMed · Cited by 77
Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells
Desch, P., Asslaber, D., Kern, D., Schnidar, H., Mangelberger, D., Alinger, B., Stöcher, M., Hofbauer, S., Neureiter, D., Tinhofer, I., et al. (2010) · Oncogene · doi:10.1038/onc.2010.243 · Cited by 71
Antimony trioxide-induced apoptosis is dependent on SEK1/JNK signaling
Mann, K. K., Davison, K. L., Colombo, M., Colosimo, A. L., Diaz, Z., Padovani, A. M. S., Guo, Q., Scrivens, P. J., Gao, W., Mader, S., et al. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.06.017 · Cited by 67
Differential expression of Sonic hedgehog and Gli1 in hematological malignancies
Bai, L.-Y., Chiu, C.-F., Lin, C.-W., Hsu, N.-Y., Lin, C.-L., Lo, W.-J., & Kao, M.-C. (2007) · Leukemia · doi:10.1038/sj.leu.2404978 · Cited by 66
Kinjo, K., Kizaki, M., Muto, A., Fukuchi, Y., Umezawa, A., Yamato, K., Nishihara, T., Hata, J., Ito, M., Ueyama, Y., et al. (2000) · Leukemia · doi:10.1038/sj.leu.2401646 · Cited by 63
Fei, D. L., Li, H., Kozul, C. D., Black, K. E., Singh, S., Gosse, J. A., DiRenzo, J., Martin, K. A., Wang, B., Hamilton, J. W., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2898 · Cited by 59
Recombinant EWS-FLI1 Oncoprotein Activates Transcription
Üren, A., Tcherkasskaya, O., & Toretsky, J. A. (2004) · Biochemistry · doi:10.1021/bi048776q · Cited by 57
Self-citationTargeted Degradation of the AML1/MDS1/EVI1 Oncoprotein by Arsenic Trioxide
Shackelford, D. B., Kenific, C. M., Blusztajn, A., Waxman, S., & Ren, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1774 · Cited by 46
White, D. E., & Burchill, S. A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.045 · Cited by 27
Cited by
Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
Kool, M., Jones, D. T. W., Jäger, N., Northcott, P. A., Pugh, T. J., Hovestadt, V., Piro, R. M., Esparza, L. A., Markant, S. L., Remke, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.004 · Cited by 762
Clara, J. A., Monge, C., Yang, Y., & Takebe, N. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0293-2 · Cited by 752
Targeting the Sonic Hedgehog Signaling Pathway: Review of Smoothened and GLI Inhibitors
Rimkus, T., Carpenter, R., Qasem, S., Chan, M., & Lo, H.-W. (2016) · Cancers · doi:10.3390/cancers8020022 · Cited by 581
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
Amakye, D., Jagani, Z., & Dorsch, M. (2013) · Nature Medicine · doi:10.1038/nm.3389 · Cited by 547
A highlight on Sonic hedgehog pathway
Carballo, G. B., Honorato, J. R., de Lopes, G. P. F., & Spohr, T. C. L. D. S. E. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0220-7 · Cited by 460
Metadata
- Authors
- Beauchamp, E. M., Ringer, L., Bulut, G., Sajwan, K. P., Hall, M. D., Lee, Y.-C., Peaceman, D., Özdemirli, M., Rodriguez, O., Macdonald, T. J., Albanese, C., Toretsky, J. A., & Üren, A.
- Venue
- Journal of Clinical Investigation
- Published
- 2011-01-04
- Volume
- 121
- Issue
- 1
- Pages
- 148-160
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2010515415
- Cited by
- 351
- References
- 54
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.